A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults.
Kiseleva I, Isakova-Sivak I, Stukova M, Erofeeva M, Donina S, Larionova N, Krutikova E, Bazhenova E, Stepanova E, Vasilyev K, Matyushenko V, Krylova M, Galatonova J, Ershov A, Lioznov D, Sparrow EG, Torelli G, Rudenko L.
Kiseleva I, et al. Among authors: ershov a.
Vaccines (Basel). 2020 Jun 10;8(2):296. doi: 10.3390/vaccines8020296.
Vaccines (Basel). 2020.
PMID: 32532097
Free PMC article.